, Tracking Stock Market Picks
Enter Symbol:
Parexel International Corporation (PRXL) [hlAlert]

up 40.54 %

Parexel International Corporation (PRXL) rated Overweight with price target $52 by Barclays

Posted on: Thursday,  Jan 30, 2014  1:25 PM ET by Barclays

Barclays rated Overweight Parexel International Corporation (NASDAQ: PRXL) on 01/30/2014, when the stock price was $49.25. Since
then, Parexel International Corporation has gained 40.55% as of 01/25/2016's recent price of $69.22.
If you would have followed this Barclays's recommendation on PRXL, you would have gained 40.54% of your investment in 725 days.

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/30/2014 1:25 PM Buy
49.25 52.00
as of 10/17/2014
1 Week up  1.80 %
1 Month down  -3.95 %
3 Months up  11.64 %
1 YTD up  20.28 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy